Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study

General Info

Geography

China (CHN)

Beijing

Coverage type

Subnational

Time period covered

January, 2020 - December, 2022

Data type

Scientific literature

Keywords

Schizophrenia

Citation

Authors

Chen X, Fan Y, Ren W, Sun M, Guan X, Xiu M, Li S

Journal

Front Pharmacol

Pages

1264591

Publication year

2023

Suggested citation

Chen X, Fan Y, Ren W, Sun M, Guan X, Xiu M, Li S. Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study. Front Pharmacol. 2023; 14: 1264591.